BanuAygunMD
Pediatric Hematology & Oncology • New Hyde Park, NYPediatric Anemia and Red Blood Cell Hematology, Pediatric Platelet Disorder Hematology
Associate Chief, Hematology Section Head, Sickle Cell Disease
Dr. Aygun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
269-01 76th Avenue
New Hyde Park, NY 11040Phone+1 718-470-3460Fax+1 718-343-4642- Is this information wrong?
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Pediatric Hematology/Oncology, 1997 - 2000
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 1994 - 1997
Hacettepe University FOMClass of 1992
Certifications & Licensure
NY State Medical License 2000 - 2025
TN State Medical License 2007 - 2014
IL State Medical License 1999 - 2005- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease Start of enrollment: 2006 Mar 03
- The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2 Start of enrollment: 2010 May 01
- Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias Start of enrollment: 2014 Apr 17
- Join now to see all
Publications & Presentations
PubMed
- Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.Alexandra Power-Hays, George A Tomlinson, Leon Tshilolo, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, T...> ;American Journal of Hematology. 2024 Apr 1
- Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth wi...Nancy S Green, Deepa Manwani, Banu Aygun, Abena Appiah-Kubi, Kim Smith-Whitley, Yina Castillo, Lucy Soriano, Haomiao Jia, Arlene M Smaldone> ;Pediatric Blood & Cancer. 2024 Apr 1
- 2 citationsHemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusion.Yunfeng Liu, Shan Su, Sarah Shayo, Weili Bao, Mouli Pal, Kai Dou, Patricia A Shi, Banu Aygun, Sally Campbell-Lee, Cheryl A Lobo, Avital Mendelson, Xiuli An, Deepa Manw...> ;The Journal of Clinical Investigation. 2023 Sep 15
- Join now to see all
Abstracts/Posters
- Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan AfricaBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan AfricaBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Benefit and Safety of Isovolemic Hemodilution Prior to Red Cell Exchange in Chronically Transfused Sickle Cell PatientsBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Corticosteroids May Harm People with Sickle Cell DiseaseApril 28th, 2022
- Addressing Unmet Needs in SCDDecember 20th, 2023
Sickle Cell Disease Association of AmericaDecember 3rd, 2019- Join now to see all
Hospital Affiliations
Cohen Childrens Medical CenterNew Hyde Park, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
